Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study.
Related Research units
Abstract
Health-related quality of life (HRQoL) worsens with multiple sclerosis (MS) relapses and disease progression. Common symptoms including depression and fatigue may contribute to poor HRQoL.
Bibliographical data
| Original language | English |
|---|---|
| Article number | 11 |
| ISSN | 1352-4585 |
| Publication status | Published - 2011 |
| pubmed | 21727148 |
|---|
